But there was no discernable bump in vaccinations after the Pfizer approval, which was heavily promoted by President Joe Biden and other federal officials.
Vaccinations peaked last spring at more than 3 million per day, and now average less than 750,000 per day.
The vaccine includes a warning about a rare type of heart inflammation that mostly occurs in young men following the second dose.
“The public can be assured that this vaccine was approved in keeping with the FDA’s rigorous scientific standards,” said Dr.
With full approval, Moderna will now market the vaccine under the brand name, Spikevax.
In the U.S., Moderna is used only by adults, for initial vaccination and as a half-dose booster.